Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Other Non-Current Liabilities: 2015-2024

Historic Other Non-Current Liabilities for Editas Medicine (EDIT) over the last 8 years, with Dec 2024 value amounting to $3.1 million.

  • Editas Medicine's Other Non-Current Liabilities rose 42.88% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year increase of 42.88%. This contributed to the annual value of $3.1 million for FY2024, which is 70.67% up from last year.
  • Per Editas Medicine's latest filing, its Other Non-Current Liabilities stood at $3.1 million for FY2024, which was up 70.67% from $1.8 million recorded in FY2023.
  • Editas Medicine's Other Non-Current Liabilities' 5-year high stood at $27.5 million during FY2020, with a 5-year trough of $1.8 million in FY2023.
  • For the 2-year period, Editas Medicine's Other Non-Current Liabilities averaged around $2.4 million, with its median value being $2.4 million (2023).
  • Data for Editas Medicine's Other Non-Current Liabilities shows a peak YoY spiked of 2,749,900.00% (in 2020) over the last 5 years.
  • Editas Medicine's Other Non-Current Liabilities (Yearly) stood at $27.5 million in 2020, then reached $1.8 million in 2023, then surged by 70.67% to $3.1 million in 2024.